<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Stolp ZD</submitter><funding>NIAID NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>NINDS NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>110647</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9074372</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>39(2)</volume><pubmed_abstract>Unicellular eukaryotes have been suggested as undergoing self-inflicted destruction. However, molecular details are sparse compared with the mechanisms of programmed/regulated cell death known for human cells and animal models. Here, we report a molecular cell death pathway in Saccharomyces cerevisiae leading to vacuole/lysosome membrane permeabilization. Following a transient cell death stimulus, yeast cells die slowly over several hours, consistent with an ongoing molecular dying process. A genome-wide screen for death-promoting factors identified all subunits of the AP-3 complex, a vesicle trafficking adapter known to transport and install newly synthesized proteins on the vacuole/lysosome membrane. To promote cell death, AP-3 requires its Arf1-GTPase-dependent vesicle trafficking function and the kinase Yck3, which is selectively transported to the vacuole membrane by AP-3. Video microscopy revealed a sequence of events where vacuole permeability precedes the loss of plasma membrane integrity. AP-3-dependent death appears to be conserved in the human pathogenic yeast Cryptococcus neoformans.</pubmed_abstract><journal>Cell reports</journal><pubmed_title>Yeast cell death pathway requiring AP-3 vesicle trafficking leads to vacuole/lysosome membrane permeabilization.</pubmed_title><pmcid>PMC9074372</pmcid><funding_grant_id>R01 AI152078</funding_grant_id><funding_grant_id>R21 AI144373</funding_grant_id><funding_grant_id>R01 HL059842</funding_grant_id><funding_grant_id>R01 AI153414</funding_grant_id><funding_grant_id>R01 GM077875</funding_grant_id><funding_grant_id>R21 NS127076</funding_grant_id><funding_grant_id>R01 AI052733</funding_grant_id><funding_grant_id>R21 AI115016</funding_grant_id><pubmed_authors>Liu Y</pubmed_authors><pubmed_authors>Lin S</pubmed_authors><pubmed_authors>Pineda FJ</pubmed_authors><pubmed_authors>Hardwick JM</pubmed_authors><pubmed_authors>Kulkarni M</pubmed_authors><pubmed_authors>Jalisi A</pubmed_authors><pubmed_authors>Stolp ZD</pubmed_authors><pubmed_authors>Casadevall A</pubmed_authors><pubmed_authors>Teng X</pubmed_authors><pubmed_authors>Cunningham KW</pubmed_authors><pubmed_authors>Zhu C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Yeast cell death pathway requiring AP-3 vesicle trafficking leads to vacuole/lysosome membrane permeabilization.</name><description>Unicellular eukaryotes have been suggested as undergoing self-inflicted destruction. However, molecular details are sparse compared with the mechanisms of programmed/regulated cell death known for human cells and animal models. Here, we report a molecular cell death pathway in Saccharomyces cerevisiae leading to vacuole/lysosome membrane permeabilization. Following a transient cell death stimulus, yeast cells die slowly over several hours, consistent with an ongoing molecular dying process. A genome-wide screen for death-promoting factors identified all subunits of the AP-3 complex, a vesicle trafficking adapter known to transport and install newly synthesized proteins on the vacuole/lysosome membrane. To promote cell death, AP-3 requires its Arf1-GTPase-dependent vesicle trafficking function and the kinase Yck3, which is selectively transported to the vacuole membrane by AP-3. Video microscopy revealed a sequence of events where vacuole permeability precedes the loss of plasma membrane integrity. AP-3-dependent death appears to be conserved in the human pathogenic yeast Cryptococcus neoformans.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Apr</publication><modification>2026-05-31T21:00:00.173Z</modification><creation>2025-02-19T04:21:08.062Z</creation></dates><accession>S-EPMC9074372</accession><cross_references><pubmed>35417721</pubmed><doi>10.1016/j.celrep.2022.110647</doi></cross_references></HashMap>